These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25482184)

  • 1. Targeted purification development enabled by computational biophysical modeling.
    Insaidoo FK; Rauscher MA; Smithline SJ; Kaarsholm NC; Feuston BP; Ortigosa AD; Linden TO; Roush DJ
    Biotechnol Prog; 2015; 31(1):154-64. PubMed ID: 25482184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal chromatography: an efficient tool in downstream processing of proteins.
    Kallberg K; Johansson HO; Bulow L
    Biotechnol J; 2012 Dec; 7(12):1485-95. PubMed ID: 23139192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of protein selectivity in multimodal chromatography using in silico designed Fab fragment variants.
    Karkov HS; Krogh BO; Woo J; Parimal S; Ahmadian H; Cramer SM
    Biotechnol Bioeng; 2015 Nov; 112(11):2305-15. PubMed ID: 25950863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of hydrophobic charge-induction chromatography: interactions between the immobilized 4-mercaptoethyl-pyridine ligand and IgG.
    Lin DQ; Tong HF; Wang HY; Shao S; Yao SJ
    J Chromatogr A; 2012 Oct; 1260():143-53. PubMed ID: 22975355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
    Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
    Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants.
    Buyel JF; Fischer R
    Biotechnol J; 2014 Apr; 9(4):566-77. PubMed ID: 24478119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purifying biopharmaceuticals: knowledge-based chromatographic process development.
    Hanke AT; Ottens M
    Trends Biotechnol; 2014 Apr; 32(4):210-20. PubMed ID: 24630477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An orientation sensitive approach in biomolecule interaction quantitative structure-activity relationship modeling and its application in ion-exchange chromatography.
    Kittelmann J; Lang KM; Ottens M; Hubbuch J
    J Chromatogr A; 2017 Jan; 1482():48-56. PubMed ID: 28038836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional insights on folate receptor α (FRα) by homology modeling, ligand docking and molecular dynamics.
    Della-Longa S; Arcovito A
    J Mol Graph Model; 2013 Jul; 44():197-207. PubMed ID: 23880302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on biomimetic affinity chromatography with short peptide ligands and its application to protein purification.
    Fang YM; Lin DQ; Yao SJ
    J Chromatogr A; 2018 Oct; 1571():1-15. PubMed ID: 30097342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioanalytical LC-MS/MS of protein-based biopharmaceuticals.
    van den Broek I; Niessen WM; van Dongen WD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():161-79. PubMed ID: 23685427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of mixed mode resins for the purification of antibodies.
    Voitl A; Müller-Späth T; Morbidelli M
    J Chromatogr A; 2010 Sep; 1217(37):5753-60. PubMed ID: 20701917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of advanced host cell protein enrichment and detection strategies to enable process relevant spike challenge studies.
    Soderquist RG; Trumbo M; Hart RA; Zhang Q; Flynn GC
    Biotechnol Prog; 2015; 31(4):983-9. PubMed ID: 26014278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of multi-modal high-salt binding ion-exchange chromatography using quantitative structure-property relationship modeling.
    Yang T; Breneman CM; Cramer SM
    J Chromatogr A; 2007 Dec; 1175(1):96-105. PubMed ID: 17991474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insight into the ligand-IgG interactions for 4-mercaptoethyl-pyridine based hydrophobic charge-induction chromatography.
    Lin DQ; Tong HF; Wang HY; Yao SJ
    J Phys Chem B; 2012 Feb; 116(4):1393-400. PubMed ID: 22214397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phenyl sepharose ligand density on protein monomer/aggregate purification and separation using hydrophobic interaction chromatography.
    McCue JT; Engel P; Thömmes J
    J Chromatogr A; 2009 Feb; 1216(6):902-9. PubMed ID: 19100554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein purification using chromatography: selection of type, modelling and optimization of operating conditions.
    Asenjo JA; Andrews BA
    J Mol Recognit; 2009; 22(2):65-76. PubMed ID: 18546092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity chromatography: general methods.
    Urh M; Simpson D; Zhao K
    Methods Enzymol; 2009; 463():417-38. PubMed ID: 19892186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.